Samuel Agresta

Chief Medical Officer, INFINITY PHARMACEUTICALS, INC.

Companies

OnKure Therapeutics, Inc.Chief Medical Officer Oct 8, 2024 to now¹
Foghorn Therapeutics Inc.Chief Medical Officer Oct 22, 2020 to Sep 13, 2023²
INFINITY PHARMACEUTICALS, INC.Board member Oct 16, 2019 to Jun 16, 2022³
INFINITY PHARMACEUTICALS, INC.Chief Medical Officer Aug 7, 2018 to Jan 7, 2019⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Foghorn Therapeutics Inc. FHTX0 shares⁵Aug 16, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 16, 2023Sold 311,297 shares at $8.25 of Foghorn Therapeutics Inc.⁵
Aug 16, 2023Exercised options 311,297 shares at $3.72 of Foghorn Therapeutics Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROnKure Therapeutics, Inc., Chief Medical Officer
2
SEC EDGARFoghorn Therapeutics Inc., Chief Medical Officer
3
SEC EDGARINFINITY PHARMACEUTICALS, INC., Board member
4
SEC EDGARINFINITY PHARMACEUTICALS, INC., Chief Medical Officer
5
SEC EDGARFoghorn Therapeutics Inc. shares after the filing of Aug 16, 2023